期刊文献+

骨髓移植治疗Duchenne型肌营养不良症模型鼠后dystrophin相关蛋白表达 被引量:2

Expression of dystrophin-associated proteins in skeletal muscles of Duchenne mus cular dystrophy model mouse after bone marrow transplantation
原文传递
导出
摘要 目的观察骨髓移植治疗Duchenne型肌营养不良症(DMD)模型鼠—mdx鼠后,β-dystroglycan和α-sarcoglycan在肌膜上的表达情况。方法以正常C57鼠作为供体,以mdx鼠作为受体进行骨髓移植,在移植后2、4、6个月分别进行mdx鼠骨骼肌的β-dystroglycan和α-sarcoglycan免疫荧光染色,计算阳性细胞的荧光积分光密度,与C57鼠及未移植的mdx鼠进行比较。结果在骨髓移植后2、4、6个月mdx鼠骨骼肌肌膜上β-dystroglycan和α-sarcoglycan的表达量均有随时间的延长逐渐增加的趋势,至移植后6个月时,二者的表达量明显高于未治疗的mdx鼠。结论骨髓移植可使mdx鼠的dystrophin相关蛋白在病损骨骼肌细胞膜上表达增加,其对维持肌膜的稳定性、促进肌肉的恢复有重要意义。 Objective To observe the expression of dystrophin-associated proteins (DAPs) in skeletal muscles of mdx mice after bone marrow transplantatio n (BMT). Methods Bone marrow cells of normal C57 mice were cultured in vit ro, and transplanted into mdx mice irradiated lethally through tail veins. 2, 4 and 6 months after transplantation, the expression of β-dystroglycan and α-sar coglycan on myocyte membranes in mdx mice were detected by fluorescent immunohis tochemical staining, and the integral optical density of positive fibers were ca lculated and then compared with that of untreated mdx mice. Results The ex pression of β-dystroglycan and α-sarcoglycan on myocyte membranes in mdx mice increased with time after BMT. 6 months after BMT, their expressions were signif icantly higher than that in the untreated mice and so it was with the integral o ptical density of positive fibers. Conclusion BMT can restore β-dystrogly can and α-sarcoglycan on myocyte members of mdx mice, which is key to keep sarc olemma stable and promote the recovery from muscular dystrophy and weakness.
出处 《中华神经医学杂志》 CAS CSCD 2005年第7期666-668,共3页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(30170337) 广东省卫生厅科研基金(B2003072) 广州医学院博士启动基金(02-Q-01)
关键词 DUCHENNE型肌营养不良症 骨髓移植 dystrophin相关蛋白 Duchenne muscular dystrophy Bone marrow transplantation Dystrophin- associated proteins
  • 相关文献

参考文献8

  • 1Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma[J]. Cire Res, 2004, 94(8): 1023-1031.
  • 2Krag T, Gyrd-Hansen M, Skhurana T. Harnessing the potential of dystrophin-related proteins for meliorating Duchenne's muscular dystrophy[J]. Acta Physiol Scand, 2001, 171(3): 349-358.
  • 3Rivas E, Teijeira S, dos Santos MR, et al. Beta-sarcoglycanopathy (LGMD 2E) in a Spanish family [J]. Acta Myol, 2004, 23 (3):159-162.
  • 4Ozawa E, Mizuno Y, Hagiwara Y, et al. Molecular and cell biology of the sarcoglycan complex[J]. Muscle Nerve, 2005.
  • 5Cote PD, Moukhles H, Lindenbaum M, et al. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses [J]. Nature Genetics, 1999, 23 (3):338-342.
  • 6张为西,张成,刘焯霖,王训,刘晓蓉.建立Duchenne型肌营养不良鼠的骨髓移植模型[J].中山医科大学学报,2001,22(2):89-92. 被引量:13
  • 7Rafeal JA, Sunada Y, Cole NM. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform[J]. Hum Mol Genet,1994, 3(10): 1725-1733.
  • 8李中,张成,谢有梅,陈国俊,刘晓蓉.骨髓间质干细胞移植治疗DMD模型鼠的肌组织dystrophin/utrophin表达[J].中国医学科学院学报,2004,26(3):294-297. 被引量:7

二级参考文献15

  • 1李洵桦,梁秀龄,刘焯霖,潘锡榜,胡学强,张成,周钰倩,陈嵘,张影如,潘贺葵,欧翠华,卢锡林.957例神经遗传病分析[J].中华医学遗传学杂志,1994,11(6):372-374. 被引量:33
  • 2赵泽坤 丛建波.短期培养小鼠骨髓细胞的增殖、分化及其移植效果[J].中华放射医学与防护杂志,1986,6(2):99-99.
  • 3郑德先,现代实验血液学研究方法与技术,1999年,24页
  • 4陈实,移植免疫学,1998年,104页
  • 5赵泽坤,中华放射医学与防护杂志,1986年,6卷,2期,99页
  • 6Wang JS, Shum-Tim D, Galipeau J, et al. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg, 2000, 120(5):999-1005
  • 7Deconinck AE, Rafael JA, Skinner JA, et al. Utrophindystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell, 1997, 90(4):717-727
  • 8Koc ON, Lazarus HM. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant, 2001, 27(3):235-239
  • 9Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001, 19(3):180-192
  • 10Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol, 2000, 28(8):875-884

共引文献18

同被引文献16

  • 1郑卉,张成,熊符.干细胞移植治疗Duchenne型肌营养不良症的研究进展[J].中华神经医学杂志,2006,5(11):1182-1183. 被引量:3
  • 2Fortina P, Cheng J, Shoffner M A, et al. Diagnosis of Duchenne/ Becker muscular dystrophy and quantitative identification of carrier status by use of entangled solution capillary electrophoresis [J]. Clin Chem, 1997, 43(5) :745-751.
  • 3Lee S H, Kwak I P, Cha K E, et al. Preimplantation diagnosis of non-deletion Duchenne muscular dystrophy (DMD) by linkage polymerase chain reaction analysis [J]. Mol Hum Reprod, 1998, 4 (4) : 345-349.
  • 4Xiao Y, Jiang X, Wang R. Screening for DMD/BMD deletion carriers by fluorescence in situ hybridization [J]. Genet Test, 2003, 7(3) : 195-201.
  • 5Mallikarjuna Rao G N, Hussain T, Geetha Devi N, et al. Dystrophin gene deletions in South Indian Duchenne muscular dystrophy patients[J]. Indian J Med Sci, 2003, 57( 1 ) : 1-6.
  • 6Beggs A H, Koenig M, Boyce F M, et aL Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction [J]. Hum Genet, 1990, 86( 1 ):45-48.
  • 7Blonden L A, den Dunnen J T, van Paassen H M, et al. High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization [J]. Nucleic Acids Res, 1989, 17(14):5611- 5621.
  • 8Kim U K, Chae J J, Lee S H, et al. Molecular diagnosis of Duchenne/Becker muscular dystrophy by polymerase chain reaction and microsatellite analysis [J ]. Mol Cells, 2002, 13 (3) : 385-388.
  • 9王训,韩永升,韩咏竹,胡纪源,李凯,喻绪恩,杨任民,杨斌.成肌细胞移植治疗DMD模型-mdx鼠骨骼肌Dystrophin表达的实验研究[J].安徽医学,2009,30(2):101-103. 被引量:3
  • 10许忆峰,杨晓凤,吴雁翔,王红梅,张轶斌,吕乃武,单鸿,崔激平,周金旭,尹富华.自体骨髓干细胞移植治疗肢带型肌营养不良症33例[J].中国组织工程研究与临床康复,2009,13(32):6345-6348. 被引量:3

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部